Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combination strategies to maximize the benefits of cancer immunotherapy. | J Hematol Oncol | 2021 | 34579759 | PubTator, text mining | PubMed |
| How Immunotherapy Has Changed the Continuum of Care in Hepatocellular Carcinoma. | Cancers (Basel) | 2021 | 34572944 | PubTator, text mining | PubMed |
| Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer. | Cells | 2021 | 34572028 | PubTator, text mining | PubMed |
| New Immunotherapeutic Approaches for Glioblastoma. | J Immunol Res | 2021 | 34557553 | PubTator, text mining | PubMed |
| Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer. | J Clin Lab Anal | 2021 | 34555232 | PubTator, text mining | PubMed |
| Integrated Bioinformatic Analysis of Competing Endogenous RNA Network of Choriocarcinoma. | Med Sci Monit | 2021 | 34538870 | PubTator, text mining | PubMed |
| Enhanced target-specific delivery of docetaxel-loaded nanoparticles using engineered T cell receptors. | Nanoscale | 2021 | 34533174 | PubTator, text mining | PubMed |
| Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages. | BMC Cancer | 2021 | 34496797 | PubTator, text mining | PubMed |
| Cancer testis antigens and genomic instability: More than immunology. | DNA Repair (Amst) | 2021 | 34481156 | PubTator, text mining | PubMed |
| Transcriptional overlap links DNA hypomethylation with DNA hypermethylation at adjacent promoters in cancer. | Sci Rep | 2021 | 34462486 | PubTator, text mining | PubMed |
| DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. | Clin Epigenetics | 2021 | 34452630 | PubTator, text mining | PubMed |
| Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies. | Viruses | 2021 | 34452286 | PubTator, text mining | PubMed |
| Identification of Toxocara canis Antigen-Interacting Partners by Yeast Two-Hybrid Assay and a Putative Mechanism of These Host-Parasite Interactions. | Pathogens | 2021 | 34451413 | PubTator, text mining | PubMed |
| CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy. | J Exp Clin Cancer Res | 2021 | 34446084 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer. | Cancers (Basel) | 2021 | 34439290 | PubTator, text mining | PubMed |
| Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia? | Cancers (Basel) | 2021 | 34439275 | PubTator, text mining | PubMed |
| Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies. | Transl Lung Cancer Res | 2021 | 34430349 | PubTator, text mining | PubMed |
| Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma. | J Immunother Cancer | 2021 | 34413169 | PubTator, text mining | PubMed |
| Proteomic analysis of ubiquitination substrates reveals a CTLH E3 ligase complex-dependent regulation of glycolysis. | FASEB J | 2021 | 34383978 | PubTator, text mining | PubMed |
| The Co-Expression of Melanoma-Antigen Family a Proteins and New York Esophageal Squamous Cell Carcinoma-1 in Breast Cancer: A Pilot Study. | Cancer Manag Res | 2021 | 34377031 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=18